Cathie Wood — known for her innovation ETFs that garnered billions in inflows during the pandemic — said Ark Invest is internally testing a fund that takes the strategy a step further by simultaneously betting against major stocks in the benchmarks that are being disrupted.
«We're testing out a portfolio but it's really Ark on steroids,» Wood told CNBC's «Squawk Box» on Wednesday. Wood said she wants to test the strategy on Ark's employees and did not say when the fund would be made available to retail investors.
«We think the benchmarks are where the big risks are long-term because they are filling up with value-traps, those companies that have done very well historically but are going to be disintermediated and disrupted by the massive
Read more on cnbc.com